Vol 14, No 2 (April 30, 2026): Annals of Translational Medicine

Original Article | Data-Driven Clinical Practice and Policy Making

Over-the-scope clips versus standard endoscopic therapy as first-line treatment for bleeding peptic ulcer disease: a systematic review and meta-analysis
Hazem Abosheaishaa, Mohammed Y. Youssef, Mohamed H. Eldesouki, Mohamad Elgozair, Mina Iskander, Hossam Elnaggar, Layth Alzubaidy, Sharif Abbas, Ahmed Elsayed Alzamzamy, Arnold Forlemu, Madhavi Reddy
Annals of Translational Medicine  
2026;
14
(2)
:14
.

Original Article | Emerging Medical Technology Innovation and Translation

A standardised and reproducible method for en bloc multi-visceral organ retrieval in a porcine model
Dylan R. Barnett, Rohan Bhattacharjya, Jake Bastian, Akshay Kanhere, David Daniel, Shantanu Bhattacharjya
Annals of Translational Medicine  
2026;
14
(2)
:15
.

Review Article | Data-Driven Clinical Practice and Policy Making

Is pulmonary hypertension still a contraindication for lung volume reduction?—a narrative review of contemporary evidence
Munir Adamu Bala, Henry O’Connor, Ra’fat Tawalbeh, Vasileios Kouritas
Annals of Translational Medicine  
2026;
14
(2)
:16
.
Fertility preservation in young women with breast cancer: a narrative review of effectiveness, oncologic safety, and clinical practice implications
Renata Arruda Cerqueira, Daniel Steffens, Maria Eduarda Alves Pimenta Rosa, Ariane Vieira Carvalho, Ana Paula Drummond-Lage
Annals of Translational Medicine  
2026;
14
(2)
:17
.
Calcium montmorillonite clay: a clinically oriented narrative review of emerging perioperative and supportive applications
Mitchell K. Ng, David Jacofsky, Wael Barsoum, Michael A. Mont
Annals of Translational Medicine  
2026;
14
(2)
:18
.

Review Article | Drug and Biomaterials Screening and Development

Development of pharmacological interventions for the treatment of sarcopenia
Dan Yang, Lin Su, Liying Zhang, Yina Li, Tingxuan Huang, Xiaoli Huang
Annals of Translational Medicine  
2026;
14
(2)
:19
.

Editorial Commentary | Emerging Therapeutics

Mitapivat for sickle cell disease: the time is ripe for a new therapy
Aaron N. Cheng, Hanny Al-Samkari
Annals of Translational Medicine  
2026;
14
(2)
:20
.

Editorial Commentary | Clinical Studies

Propofol-based total intravenous anesthesia and recurrence-free survival after hepatectomy—does it improve outcomes?
Ying Qiu Zhou, Rodney A. Gabriel
Annals of Translational Medicine  
2026;
14
(2)
:21
.

Editorial Commentary | Biomarkers Sciences

Risk prediction in primary angle closure suspects: current perspectives
Teresa Laborda-Guirao, Antonio Hidalgo-Torres, José María Sánchez-González, Timoteo González-Cruces
Annals of Translational Medicine  
2026;
14
(2)
:22
.

Editorial Commentary | Emerging Medical Technology Innovation and Translation

Seeing is not enough: why introducer choice matters in hyperangulated videolaryngoscopy
Manuel Ángel Gómez-Ríos, Samuel Ern Hung Tsan, Miguel Á. Fernández-Vaquero, Alfredo Abad-Gurumeta
Annals of Translational Medicine  
2026;
14
(2)
:24
.

Editorial Commentary | Omics Sciences

Towards haplotypes of blood group genes: the impact of long-read sequencing in molecular immunohematology
Lea Wörner, Peter Bugert
Annals of Translational Medicine  
2026;
14
(2)
:25
.

Editorial Commentary | Clinical Studies

Breaking through the azacitidine plateau?—venetoclax in high-risk myelodysplastic syndrome
Yuju An, Theodoros Karantanos
Annals of Translational Medicine  
2026;
14
(2)
:26
.